Medical Countermeasures for Radiation Exposure and Related Injuries Characterization of Medicines FDA-Approval Status and Inclusion into the Strateg

The authors outline the dearth of information on FDA-approved medical countermeasures for acute radiation syndrome (ARS). They review the status of medical countermeasures for ARS that are available and those which could be used in exceptional circumstances. They also highlight experimental countermeasures not yet approved by the FDA for use in humans and the need for additional research on radiation injury and its treatment.
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.